Efficacy Methadone for Management Postoperative Pain After the Use of Anesthesia Intravenous in Laparoscopic Cholecystectomy
Study Details
Study Description
Brief Summary
The aim of this study is to compare the efficacy of methadone versus morphine in dealing with postoperative pain, in laparoscopic cholecystectomy under total intravenous anesthesia (TIVA); Efficacy is defined in terms of the difference of milligrams in morphine used as rescue analgesia postoperatively. Our hypothesis is that methadone is more effective than morphine for postoperative pain treatment.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
| N/A |
Detailed Description
Patients undergo laparoscopic cholecystectomy at Almirante Nef Naval Hospital will be recruited, between March and July 2013. The sample size was calculated to obtain an average difference of 4 mg of morphine (DE 1.5) to 3 mg of morphine (DE 1.5), with a power of 80% and a significance level of 0.05. This came down to 36 randomized patients into each group, so 86 patients will be recruited considering a 15% loss to follow up.
Before signing an informed consent, we will explain to them how to classify pain intensity numerical rating scale (NRS) and this will be evaluated periodically during the first 24 hours after surgery.
General anesthesia will be based on Remifentanil and Propofol, titrated to achieve bispectral index (BIS) between 40 and 60. Patients will be randomized into methadone group (ME) and morphine group (MO), they will receive 0.08 mg / kg bolus of methadone or 0.08 mg / kg bolus of morphine as applicable at the time of beginning surgery. Postoperative analgesia will be standard for both groups. Patient´s demographic data will be filed as well as surgical timings.
All patients will remain in the anesthetic recovery room for the first two hours , to get a record taken of vital signs and measurement of NRS at 5, 15, 30, 60 and 120 minutes. If NRS is greater than or equal to 4, 1 mg of morphine ev will be used as analgesic rescue. In room measuring NRS continue hospitalized at 4, 8, 12 and 24 hours postoperatively and were used as rescue analgesia if ketorolac 30mg ev NRS is greater than or equal to 4. The amount of morphine is registered and ketorolac rescue of both groups as well as pain assessment scores. The occurrence of adverse effects such as nausea, vomiting, pruritus, urinary retention and respiratory depression is also recorded in both groups, to be compared later as a secondary objective.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Active Comparator: Morphine morphine group 0.08 mg / kg, to start surgery |
Drug: Morphine
Morphine group,receive morphine 0.08 mg / kg at the start of surgery
Drug: TIVA
TIVA: General anesthesia will be based on Remifentanil and Propofol (TIVA-TCI), titrated to achieve bispectral index (BIS) between 40 and 60.
|
| Experimental: Methadone methadone group 0.08 mg / kg, to start surgery |
Drug: Methadone
Methadone group,receive methadone 0.08 mg / kg at the start of surgery
Drug: TIVA
TIVA: General anesthesia will be based on Remifentanil and Propofol (TIVA-TCI), titrated to achieve bispectral index (BIS) between 40 and 60.
|
Outcome Measures
Primary Outcome Measures
- Difference in milligrams of morphine used as rescue analgesia [First 24 hours postoperatively]
Difference in milligrams of morphine used as rescue analgesia in postoperative period in both groups
Secondary Outcome Measures
- Difference in pain scores, using the Numeric Rating Scale [First 24 hours postoperatively]
Difference in pain scores, using the Numeric Rating Scale at 5, 15, 30, 60 and 120 minutes postoperative. Also at 4, 8, 12 and 24 hours postoperatively, during hospitalization.
Other Outcome Measures
- The different of the adverse effect [First 24 hours postoperatively]
The total number of adverse effects such as nausea, vomiting, pruritus, urinary retention and respiratory depression is recorded in both groups, to be compared later as a secondary objective.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients undergoing laparoscopic cholecystectomy in the Almirante Nef Naval Hospital
-
Patients ASA 1 or 2
Exclusion Criteria:
-
Patients with renal insufficiency (creatinine> 2.0 mg / dl)
-
Patients with a history of liver failure
-
Patients with BMI> 35 kg/m2
-
Patients with hypersensitivity to the drugs in question
-
History of chronic use of opioids
-
Need for conversion to open surgery
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Almirante Nef Naval Hospital | Viña del Mar | Valparaiso | Chile |
Sponsors and Collaborators
- Universidad de Valparaiso
Investigators
- Principal Investigator: NICOLAS ARRIAZA, Physician, University Valparaiso
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- P03/13